ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 2456

$575K Total Retail Price of All Prescriptions

Rank: 171 out of 2456

383 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 383 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 383 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 13,557 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 1,017 1,017 1 9
SIMVASTATIN 707 698 2 2
FUROSEMIDE 697 697 3 8
ATENOLOL 627 605 4 6
LISINOPRIL 593 586 5 1
LEVOTHYROXINE SODIUM 522 522 6 4
OMEPRAZOLE 480 463 7 3
METOPROLOL TARTRATE 468 468 8 10
GABAPENTIN 437 432 9 16
METOPROLOL SUCCINATE 338 327 10 13
AMLODIPINE BESYLATE 250 236 11 5
HYDROCHLOROTHIAZIDE 238 228 12 7
DONEPEZIL HCL 237 237 13 23
TRAZODONE HCL 213 213 14 17
MIRTAZAPINE 204 204 15 29
DIOVAN 174 174 16 26
LACTULOSE 158 158 17 88
NAMENDA 153 153 18 42
ALLOPURINOL 150 144 19 27
GLIPIZIDE 146 142 20 46
LOSARTAN POTASSIUM 146 146 20 18
METFORMIN HCL 131 124 22 11
ATORVASTATIN CALCIUM 128 128 23 12
PREDNISONE 125 125 24 39
SPIRONOLACTONE 123 123 25 73
CARBIDOPA-LEVODOPA 121 121 26 82
HYDROCODONE-ACETAMINOPHEN 111 109 S3 27 20
ADVAIR DISKUS 110 110 28 36
SERTRALINE HCL 109 109 29 21
POTASSIUM CHLORIDE 107 107 30 33
CITALOPRAM HBR 105 95 31 14
ALENDRONATE SODIUM 92 92 32 19
DIVALPROEX SODIUM 91 91 33 51
NORTRIPTYLINE HCL 80 80 34 227
DIGOXIN 80 80 34 49
LANTUS 80 74 34 44
TRAMADOL HCL 74 74 37 24
PROAIR HFA 73 63 38 22
ESCITALOPRAM OXALATE 73 73 38 116
VANCOMYCIN HCL 71 71 40 180
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 68 40 41
PRAVASTATIN SODIUM 66 55 42 15
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 57 43 147
RANITIDINE HCL 60 60 44 31
DOXAZOSIN MESYLATE 58 58 45 71
LATANOPROST 58 58 45 156
NIFEDIPINE ER 58 58 45 61
CHOLESTYRAMINE 58 58 45 300
CLOPIDOGREL 57 57 49 55
FLUOXETINE HCL 56 48 50 45
CYMBALTA 56 56 50 65
OXYBUTYNIN CHLORIDE ER 51 34 52 94
GALANTAMINE HBR 51 51 52 285
FLUTICASONE PROPIONATE 51 51 52 30
HYDROXYZINE HCL 50 50 R 55 177
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.